Vineet Life Sciences Private Limited is set to revolutionize healthcare with its Rs. 25 crore Active Pharmaceutical Ingredients (API) Manufacturing Unit Project in Guntur, Andhra Pradesh. This initiative, producing 2450 Kg/day of APIs, aims to bolster India's self-reliance in pharmaceuticals and ensure accessible and affordable medication.
Located in Jangamaheswarapadu Village, Durgi Mandal, Guntur District, Andhra Pradesh, this API manufacturing unit will cater to high-demand medications across therapeutic areas, adhering to global quality standards and employing advanced technologies for efficiency and sustainability.
The project signifies a pivotal shift by reducing reliance on imported APIs, fostering affordability in healthcare, generating employment, and positioning Vineet Life Sciences as a frontrunner in API manufacturing. Committed to green practices, advanced technology utilization, R&D, and collaborations, Vineet Life Sciences aims to overcome challenges of clearances, raw material accessibility, workforce development, and market competition.
With a robust track record in the pharmaceutical industry, Vineet Life Sciences' initiative aligns with India's goal to boost domestic API production, diminishing dependence on imports, and enhancing the nation's pharmaceutical autonomy.
As on January, 2024. Project has gotten approvals. All approvals were granted. By January 2024, project construction will begin.
News by Rahul Yelligetti